Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs IDEXX Laboratories, Inc. — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $94.83, while IDEXX Laboratories, Inc. trades at $587.2 (market cap $46.22B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| EMB | IDXX | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $97.74 | $766.68 |
52-Week Low | $92.95 | $526.44 |
Market Cap | — | $46.22B |
Enterprise Value | — | $47.12B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
